[HTML][HTML] Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients
Abstract Coronavirus disease 2019 (COVID-19) has several extrapulmonary symptoms.
Gastrointestinal (GI) symptoms are among the most frequent clinical manifestations of …
Gastrointestinal (GI) symptoms are among the most frequent clinical manifestations of …
[HTML][HTML] Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination
R Nevola, L Criscuolo, D Beccia… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Since the first identification in December of 2019 and the fast spread of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, it has represented a dramatic …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, it has represented a dramatic …
Presence of MDSC associates with impaired antigen-specific T cell reactivity following COVID-19 vaccination in cirrhotic patients
Background and aims Cirrhosis entails high risk of serious infections and abated efficiency
of vaccination, but the underlying mechanisms are only partially understood. This study …
of vaccination, but the underlying mechanisms are only partially understood. This study …
COVID-19 alcoholic cirrhosis and non-alcoholic steatohepatitis cirrhosis outcomes among hospitalized patients in the United States: Insight from National Inpatient …
Patients with co-morbidities like cirrhosis are at risk of worse outcome from COVID-19
infection. Given limited prior studies, we evaluated outcomes associated with COVID-19 …
infection. Given limited prior studies, we evaluated outcomes associated with COVID-19 …
COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?
A Michalak, T Lach, K Szczygieł… - International Journal of …, 2024 - mdpi.com
The pandemic period due to coronavirus disease 2019 (COVID-19) revolutionized all
possible areas of global health. Significant consequences were also related to diverse …
possible areas of global health. Significant consequences were also related to diverse …
NAFLD and NASH are obesity‐independent risk factors in COVID‐19: Matched real‐world results from the large PINC AI™ Healthcare Database
JF Brozat, F Ntanios, D Malhotra, S Dagenais… - Liver …, 2024 - Wiley Online Library
Abstract Background & Aims Non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic
steatohepatitis (NASH) are potential risk factors for severe pneumonia and other infections …
steatohepatitis (NASH) are potential risk factors for severe pneumonia and other infections …
Clinical outcomes of COVID-19 in patients with liver cirrhosis-a propensity-matched analysis from a multicentric Brazilian cohort
LSM Menezes, PFS da Cunha, MC Pires… - BMC Infectious …, 2025 - Springer
Background Cirrhosis has been pointed out as a clinical entity that leads to worse clinical
prognosis in COVID-19 patients. However, this concept is controversial in the literature. We …
prognosis in COVID-19 patients. However, this concept is controversial in the literature. We …
[HTML][HTML] COVID-19 and hepatorenal syndrome
Abstract Coronavirus disease 2019 (COVID-19) is a highly infectious disease which
emerged into a global pandemic. Although it primarily causes respiratory symptoms for …
emerged into a global pandemic. Although it primarily causes respiratory symptoms for …
Factors Associated with All-Cause 30-Day Mortality in Indonesian Inpatient COVID-19 Patients at Cipto Mangunkusumo National General Hospital
Introduction: Indonesia, as a developing country, has limited data on the factors associated
with 30-day mortality in COVID-19 patients in Indonesia. As a matter of fact, study analyzing …
with 30-day mortality in COVID-19 patients in Indonesia. As a matter of fact, study analyzing …
[HTML][HTML] Clinical characteristics and outcomes of patients with severe COVID-19 and cirrhosis or liver transplant in a Brazilian quaternary center
TL Correa, MSTC Guelli… - Arquivos de …, 2024 - SciELO Brasil
HIGHLIGHTS• Specific associations between liver cirrhosis and liver transplant with poorer
outcomes in COVID-19 are still not clear.• We aimed to evaluate the clinical characteristics …
outcomes in COVID-19 are still not clear.• We aimed to evaluate the clinical characteristics …